10 November 2023
-
SANTECHTURE rolls out its intelligence-driven claims engine, THYNK, in Saudi Arabia
SAUDI ARABIA – SANTECHTURE has launched THYNK, an Intelligence-Driven Claims Engine, to its customers across the Kingdom of Saudi Arabia. This development come after the…
-
Abu Dhabi University signs science deal with Europe’s Unilabs
UAE – Abu Dhabi University’s (ADU) College of Health Sciences has entered into a Memorandum of Understanding (MoU) with Unilabs, one of the leading medical…
-
Novo Nordisk invests US$6 billion to address obesity drug shortages and global demand
DENMARK — In a strategic move to address the surging global demand for its anti-obesity drug, Wegovy, Novo Nordisk announced a substantial investment of US$6…
-
AstraZeneca secures exclusive license for promising oral GLP-1 receptor agonist in bid for weight-loss market
UNITED KINGDOM — AstraZeneca has inked an exclusive license agreement with Shanghai-based biotech Eccogene for ECC5004—an early-stage investigational oral glucagon-like peptide 1 receptor agonist (GLP-1RA)…
-
Novo Nordisk phases out Levemir in the U.S. amidst growing insulin pricing pressure
USA — Novo Nordisk, a major player in the pharmaceutical industry, has announced plans to discontinue its long-acting insulin treatment, Levemir, in the U.S. by…
-
Philips and Bill & Melinda Gates Foundation collaborate to revolutionize maternal health with AI-enhanced ultrasound technology
KENYA—Royal Philips, a global pioneer in health technology, has announced a second round of funding from the Bill and Melinda Gates Foundation, bringing the total…
-
Zulekha Hospital Dubai partners with Beit Al Khair Society to raise funds for destitute patients
UAE – Zulekha Hospital Dubai, in collaboration with Beit Al Khair Society, has introduced a new self-funding program christened Afrahoum designed to raise money for…
-
Illumina reports steady Q3 revenues amidst regulatory pressures and leadership transitions
USA — in a dynamic quarter marked by regulatory pressures and leadership changes, Illumina has disclosed that its third-quarter revenues remained steady at US$1.1 billion…
-
Bayer and Recursion Pharmaceuticals propel precision oncology in US$1.5 billion deal
GERMANY — Bayer and Recursion Pharmaceuticals have unveiled an ambitious pivot in their research collaboration, now setting their sights on precision oncology in a deal…
-
Dis-Chem Pharmacies reports a 17.2% drop in Half-Year earnings, citing economic challenges
SOUTH AFRICA—Dis-Chem Pharmacies, a South African drugstore chain, has disclosed a 17.2% reduction in half-year earnings. Dis-Chem provides healthcare in a variety of ways, including…